Bottom line
PHLAX vs JEHSX: the short answer
PHLAX (PGIM Jennison Health Sciences Fund) and JEHSX (Health Sciences Trust) share a meaningful slice of their top holdings — about 52% by weight.
But JEHSX is far broader, holding 173 positions to 55 for PHLAX, so beyond the top names it adds exposure PHLAX doesn't have.
JEHSX is cheaper at 1.04% vs 1.15% — a difference of $11 a year per $10,000 invested.
Over five years, PHLAX returned +5.5% a year vs +4.2% for JEHSX (reporting dates differ).
PHLAX has a front-end sales load of up to 5.5%; the other does not.
Updated Nov 19, 2026
PHLAX vs JEHSX side by side
| PHLAX | JEHSX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | PGIM (Prudential) | John Hancock |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.15% | 1.04% |
| Annual cost per $10k | $115 | $104 |
| 10-yr cost on $10k (prospectus) | $1,871 | $1,282 |
| Max front load | 5.5% | — |
| 12b-1 fee | 0.3% | 0.05% |
| 1-yr return | +12.7% | +19.5% |
| 5-yr return (annualized) | +5.5% | +4.2% |
| 10-yr return (annualized) | +8.9% | +8.7% |
| Best quarter | — | +23.6% |
| Worst quarter | — | −16.1% |
| Net assets (fund) | $1.4B | $251.3M |
| Number of holdings | 55 | 173 |
| Portfolio turnover | 81% | 68% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
9 of PHLAX's top 25 holdings also appear in JEHSX's top 25.
| Holding | PHLAX | JEHSX |
|---|---|---|
| Eli Lilly & Company | 17.35% | 14.30% |
| Merck & Company Inc | 6.06% | 4.21% |
| Unitedhealth Group Inc | 5.87% | 5.95% |
| Thermo Fisher Scientific Inc | 4.56% | 2.67% |
| Vertex Pharmaceuticals Inc | 3.37% | 2.38% |
| Danaher Corp | 3.28% | 1.51% |
| Intuitive Surgical Inc | 3.07% | 1.98% |
| Cvs Health Corp | 2.52% | 0.98% |
| Stryker Corp | 2.16% | 1.87% |
Source: SEC Form N-PORT
PHLAX top 10
- Eli Lilly & Company — 17.35%
- Merck & Company Inc — 6.06%
- Unitedhealth Group Inc — 5.87%
- Thermo Fisher Scientific Inc — 4.56%
- Argenx Se — 3.55%
- Vertex Pharmaceuticals Inc — 3.37%
- Danaher Corp — 3.28%
- Intuitive Surgical Inc — 3.07%
- Lonza Group Ag — 3.02%
- Cvs Health Corp — 2.52%
JEHSX top 10
- Eli Lilly and Company — 14.30%
- Johnson and Johnson — 6.33%
- UnitedHealth Group Incorporated — 5.95%
- AbbVie Inc. — 5.28%
- Merck and Co. Inc. — 4.21%
- Gilead Sciences Inc. — 2.95%
- Thermo Fisher Scientific Inc. — 2.67%
- Vertex Pharmaceuticals Incorporated — 2.38%
- Bristol-Myers Squibb Company — 2.22%
- Abbott Laboratories — 2.00%
FAQ
What is the difference between PHLAX and JEHSX?
Which is cheaper, PHLAX or JEHSX?
Should I own both PHLAX and JEHSX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.